IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

TCG Crossover Management, LLC

Portfolio Profile

CIK: 0001839948 | PALO ALTO, CA

Investment Profile

Style

Growth

Turnover

Medium

Orientation

Concentrated trader
$4.2B
AUM
54
Positions
57.45%
Top 10 Conc.
85.79%
Top 25 Conc.

Top Holdings

#SecuritySharesValue% of Portfolio
1Abivax SA American Depositary Shares(ABVX)6,007,834$800.6M19.24%
2Tango Therapeutics Inc(TNGX)9,081,201$283.9M6.82%
3CG Oncology Inc(CGON)3,670,206$260.8M6.27%
4Cogent Biosciences Inc(COGT)4,854,436$187.9M4.52%
5Immunovant Inc(IMVT)4,457,988$171.8M4.13%

Sector Allocation

Latest filing, equity positions only

Healthcare96.8% · $4.0B
Unclassified3.2% · $133.2M

Sector Rotation

Quarter-over-quarter weight changes

SectorPrev %Curr %Change
Healthcare99.79%96.8%-2.99%
Unclassified0.21%3.2%+2.99%

Cap Size Rotation

Quarter-over-quarter weight changes by market cap

AUM History

$679.1M | 26 pos.
$901.7M | 29 pos.
$1.3B | 33 pos.
$959.5M | 32 pos.
$1.2B | 36 pos.
$1.0B | 38 pos.
6
Spyre Therapeutics Inc(SYRE)
1,900,582
$168.7M
4.06%
7Dianthus Therapeutics Inc(DNTH)1,676,624$163.4M3.93%
8Mirum Pharmaceuticals Inc(MIRM)1,062,049$124.3M2.99%
9ZAI LAB LTD(ZLAB)6,137,627$116.6M2.80%
10Amylyx Pharmaceuticals Inc(AMLX)6,243,812$112.1M2.70%
Cap SizePrev %Curr %Change
Mid Cap70.28%65.36%-4.92%
Small Cap23.27%25.44%+2.17%
Micro Cap4.64%4.46%-0.18%
Unclassified0.21%3.2%+2.99%
Large Cap1.6%1.53%-0.07%
$733.1M | 38 pos.
$875.5M | 38 pos.
$2.0B | 40 pos.
$3.0B | 43 pos.
$3.5B | 49 pos.
$4.2B | 54 pos.
Q3
23
Q4
23
Q1
24
Q2
24
Q3
24
Q4
24
Q1
25
Q2
25
Q3
25
Q4
25
Q1
26
Q2
26

Recent Activity

Quarter-over-quarter position changes

12
New
7
Closed
2
Increased
9
Decreased
31
Unchanged